Nahila Justo

717 total citations · 1 hit paper
21 papers, 418 citations indexed

About

Nahila Justo is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nahila Justo has authored 21 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nahila Justo's work include Heart Failure Treatment and Management (5 papers), Cardiac pacing and defibrillation studies (3 papers) and COVID-19 Clinical Research Studies (3 papers). Nahila Justo is often cited by papers focused on Heart Failure Treatment and Management (5 papers), Cardiac pacing and defibrillation studies (3 papers) and COVID-19 Clinical Research Studies (3 papers). Nahila Justo collaborates with scholars based in Sweden, United Kingdom and United States. Nahila Justo's co-authors include Nils Wilking, Bengt Jönsson, Silvana Luciani, Eduardo Cazap, Richard McNulty, Cátia Ferreira, Paul Moss, Eleanor Barnes, Lucy Carty and Diego Rosselli and has published in prestigious journals such as Journal of the American College of Cardiology, Annals of Oncology and Age and Ageing.

In The Last Decade

Nahila Justo

20 papers receiving 404 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study

2023 86 citations Rachael A Evans, Sabada Dube et al. The Lancet Regional Health - Europe profile →

Peers

Nahila Justo

ONCOL

PRM

CCM

Hagar Elghazawy Egypt

Güngör Utkan Türkiye

Keiji Sugiyama Japan

Hasna Bouchaab Switzerland

Aude Desnoyer France

Greg Dennis United States

Saverio Virdone United Kingdom

Daniel Sheinson United States

Sara Ekberg Sweden

Mark B. Ulanja United States

Hagar Elghazawy Egypt

Nahila Justo

182 ×1.2

ONCOL

60 ×0.7

PRM

62 ×0.8

24 ×0.3

CCM

22 ×0.4

Citations per year, relative to Nahila Justo Nahila Justo (= 1×) peers Hagar Elghazawy

Countries citing papers authored by Nahila Justo

Since Specialization

Citations

This map shows the geographic impact of Nahila Justo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahila Justo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahila Justo more than expected).

Fields of papers citing papers by Nahila Justo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahila Justo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahila Justo. The network helps show where Nahila Justo may publish in the future.

Co-authorship network of co-authors of Nahila Justo

This figure shows the co-authorship network connecting the top 25 collaborators of Nahila Justo. A scholar is included among the top collaborators of Nahila Justo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahila Justo. Nahila Justo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quint, Jennifer K, Sabada Dube, Lucy Carty, et al.. (2025). Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study. Journal of Infection. 90(3). 106432–106432. 1 indexed citations

Sejersen, Thomas, Sophie Graham, Anne‐Berit Ekström, et al.. (2024). Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden. The European Journal of Health Economics. 26(1). 35–48. 2 indexed citations

Dube, Sabada, Richard McNulty, Sofie Arnetorp, et al.. (2024). 1848 Risk of severe COVID-19 increases with the number of comorbidities in fully vaccinated individuals aged ≥65: results from INFORM. Age and Ageing. 53(Supplement_1).

Escobar, Carlos, Beatriz Palacios, Victoria González, et al.. (2023). Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction. Journal of Clinical Medicine. 12(6). 2410–2410. 4 indexed citations

Evans, Rachael A, Sabada Dube, Yi Lu, et al.. (2023). Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study. The Lancet Regional Health - Europe. 35. 100747–100747. 86 indexed citations breakdown →

Escobar, Carlos, Beatriz Palacios, Victoria González, et al.. (2023). Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain. BMC Health Services Research. 23(1). 1340–1340. 2 indexed citations

Duong, Mai, Hungta Chen, Nahila Justo, et al.. (2022). PREVALENCE AND CHARACTERISTICS OF HEART FAILURE WITH PRESERVED, MILDLY REDUCED, AND REDUCED EJECTION FRACTION IN SPAIN: A RETROSPECTIVE COHORT STUDY USING BIGPAC DATABASE. Journal of the American College of Cardiology. 79(9). 454–454. 1 indexed citations

Escobar, Carlos, Beatriz Palacios, Luis Varela, et al.. (2022). Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain. BMC Health Services Research. 22(1). 1241–1241. 19 indexed citations

Escobar, Carlos, Beatriz Palacios, Luis Varela, et al.. (2022). Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain. Journal of Clinical Medicine. 11(17). 5199–5199. 23 indexed citations

10.

Justo, Nahila, et al.. (2020). Insights into Treatment Patterns in the Routine Care of Patients Diagnosed with Metastatic Castration-Resistant Prostate Cancer in Germany After the Introduction of New Therapies. 1–8. 2 indexed citations

11.

Luttropp, Karin, Mary Dozier, Nahila Justo, et al.. (2019). Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review. BMJ Open. 9(5). e027456–e027456. 20 indexed citations

12.

Wang, Xuan, et al.. (2019). Identification and mapping of worldwide sources of generic real‐world data. Pharmacoepidemiology and Drug Safety. 28(7). 899–905. 6 indexed citations

13.

Justo, Nahila, Manuel Espinoza, Diego Rosselli, et al.. (2019). Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America. Value in Health. 22(6). 739–749. 45 indexed citations

14.

Zech, Christoph J., et al.. (2016). Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial. European Radiology. 26(11). 4121–4130. 24 indexed citations

15.

McGuire, Alistair, et al.. (2015). End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes?. Expert Review of Pharmacoeconomics & Outcomes Research. 15(4). 599–605. 9 indexed citations

16.

Jönsson, Linus, Nahila Justo, Thomas Burke, et al.. (2015). Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study. European Journal of Cancer Care. 25(3). 466–477. 5 indexed citations

17.

Justo, Nahila, Nils Wilking, Bengt Jönsson, Silvana Luciani, & Eduardo Cazap. (2013). A Review of Breast Cancer Care and Outcomes in Latin America. The Oncologist. 18(3). 248–256. 100 indexed citations

18.

Kim, Kun, E Hernlund, Zoltán Hernádi, et al.. (2013). Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review. International Journal of Gynecological Cancer. 23(5). 823–832. 9 indexed citations

19.

Kim, Kun, E Hernlund, Nahila Justo, et al.. (2012). PCN50 Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review. Value in Health. 15(7). A417–A418. 1 indexed citations

20.

Leahy, Michael, Xavier García del Muro, Peter Reichardt, et al.. (2012). Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study. Annals of Oncology. 23(10). 2763–2770. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact